γδ T cells confer protection against murine cytomegalovirus (MCMV)

PLoS Pathog. 2015 Mar 6;11(3):e1004702. doi: 10.1371/journal.ppat.1004702. eCollection 2015 Mar.

Abstract

Cytomegalovirus (CMV) is a leading infectious cause of morbidity in immune-compromised patients. γδ T cells have been involved in the response to CMV but their role in protection has not been firmly established and their dependency on other lymphocytes has not been addressed. Using C57BL/6 αβ and/or γδ T cell-deficient mice, we here show that γδ T cells are as competent as αβ T cells to protect mice from CMV-induced death. γδ T cell-mediated protection involved control of viral load and prevented organ damage. γδ T cell recovery by bone marrow transplant or adoptive transfer experiments rescued CD3ε-/- mice from CMV-induced death confirming the protective antiviral role of γδ T cells. As observed in humans, different γδ T cell subsets were induced upon CMV challenge, which differentiated into effector memory cells. This response was observed in the liver and lungs and implicated both CD27+ and CD27- γδ T cells. NK cells were the largely preponderant producers of IFNγ and cytotoxic granules throughout the infection, suggesting that the protective role of γδ T cells did not principally rely on either of these two functions. Finally, γδ T cells were strikingly sufficient to fully protect Rag-/-γc-/- mice from death, demonstrating that they can act in the absence of B and NK cells. Altogether our results uncover an autonomous protective antiviral function of γδ T cells, and open new perspectives for the characterization of a non classical mode of action which should foster the design of new γδ T cell based therapies, especially useful in αβ T cell compromised patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Herpesviridae Infections / genetics
  • Herpesviridae Infections / immunology*
  • Herpesviridae Infections / pathology
  • Immunity, Cellular*
  • Mice
  • Mice, Knockout
  • Muromegalovirus / immunology*
  • Receptors, Antigen, T-Cell, gamma-delta / genetics
  • Receptors, Antigen, T-Cell, gamma-delta / immunology*
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / pathology

Substances

  • Receptors, Antigen, T-Cell, gamma-delta

Grants and funding

This work was supported in part by grants from the Centre National de la Recherche Scientifique, the Fondation pour la Recherche Médicale [DEQ20110421287], the Agence National de la Recherche [ANR-12-BSV3-0024-02], the Ligue Nationale contre le Cancer (Comités Départementaux d’Aquitaine) and the Association pour la Recherche contre le Cancer [A09/1/5022]. Camille Khairallah is supported by the Conseil Régional d’Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.